GlassScriptPhysician profile
Robert Caleb Buege
NPI 1427324433
$1,750.01
in general payments reported to CMS, 2019-2025
17 companies · $445 in 2025
The $445 reported for 2025 was more than what 92% of Pediatrics providers received nationally (typical 2025 total: $96.93).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $289 · 2020: $188 · 2021: $406 · 2022: $60.09 · 2023: $14.46 · 2024: $347 · 2025: $445.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $807.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $806.68 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Corium, LLC | $438.71 | 2021-2025 | Azstarys |
| Tris Pharma INC | $247.89 | 2019-2021 | |
| Ironshore Pharmaceuticals INC. | $149.97 | 2019-2024 | |
| Merck Sharp & Dohme LLC | $120.78 | 2020-2025 | Vaxneuvance, M-M-R II, Gardasil 9 |
| Takeda Pharmaceuticals U.S.A., INC. | $119.08 | 2019-2022 | |
| Collegium Pharmaceutical, INC. | $113.04 | 2025 | Jornay Pm |
| Sobi, INC | $99.99 | 2019 | |
| Adlon Therapeutics L.P. | $97.48 | 2019-2021 | |
| Supernus Pharmaceuticals, INC. | $70.82 | 2021-2025 | Qelbree, Qelbree |
| Sanofi Pasteur INC. | $66.02 | 2020-2024 | |
| Pfizer INC. | $62.75 | 2019-2025 | |
| Neos Therapeutics, LP | $57.51 | 2021-2025 | Cotempla Xr-Odt |
| Cranial Technologies, INC | $29.90 | 2024-2025 | Doc Band |
| Kaleo, INC. | $26.72 | 2019 | |
| Kowa Pharmaceuticals America, INC. | $17.69 | 2025 | Zoryve |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Shire North American Group INC | $16.05 | 2019 | |
| Dermira, INC. | $15.61 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Buege listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.